According to the method for evaluating the
acute kidney injury risk of the patient with the abnormal
creatinine level, a traditional single-index evaluation mode is broken through in multi-dimensional
risk evaluation, and a comprehensive AKI
risk evaluation system is established by integrating multi-dimensional clinical data such as
medical advice, medication, operation,
nursing and blood transfusion. A
time sequence data analysis technology is adopted, and the
creatinine level of a patient is continuously and dynamically monitored. A
creatinine interference model is innovatively constructed, and the influence degree of various
clinical diagnosis and treatment items on the creatinine concentration is quantified. And according to a
risk assessment result, automatic grading early warning is carried out, detailed analysis is provided for a high interference condition, and a
nephrology consultation template is generated. Based on historical data and real-time monitoring information, the future creatinine change trend of the patient can be predicted, and potential risks can be recognized in advance. Hospitals and doctors need more accurate AKI
risk assessment tools to improve
clinical decision-making efficiency, and treatment schemes can be adjusted in time according to
dynamic monitoring of creatinine level changes of patients. The
system provides an accurate, dynamic and full-process
acute kidney injury risk assessment solution, and the AKI early recognition and intervention capability is remarkably improved.